Induction of neuronal cell death by paraneoplastic Ma1 antigen

Journal of Neuroscience Research

Volumn 88, Issue 16, 2010, Pages 3508-3519

  Chen, Huai Lu ^a   D'Mello, Santosh R ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

Apoptosis; Cerebellar granule neurons; Cortical neurons; Paraneoplastic Ma1 antigen; Paraneoplastic neurological syndrome; PNMA1

Indexed keywords

ANTIGEN; BH3 PROTEIN; HOMOCYSTEIC ACID; PARANEOPLASTIC MA1 ANTIGEN; POTASSIUM; PROTEIN BCL 2; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; BRAIN CELL; CARBOXY TERMINAL SEQUENCE; CELL SURVIVAL; CONTROLLED STUDY; FEMALE; HUNTINGTON DISEASE LIKE SYNDROME; MALE; MOUSE; NERVE CELL; NERVE CELL NECROSIS; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIGENS; ANTIGENS, NEOPLASM; APOPTOSIS; BRAIN; CELLS, CULTURED; DISEASE MODELS, ANIMAL; HUNTINGTON DISEASE; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, NEUROLOGIC MUTANTS; MICE, TRANSGENIC; NERVE DEGENERATION; NERVE TISSUE PROTEINS; NEURONS; RATS; RATS, WISTAR;

EID: 78049437670     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22506     Document Type: Article

References (22)

1. Albert ML, Darnell RB. 2004. Paraneoplastic neurological degenerations: keys to tumour immunity. Nat Rev Cancer 4: 36-44.
2. Baksh S, Tommasi S, Fenton S, Yu VC, Martins LM, Pfeifer GP, Latif F, Downward J, Neel BG. 2005. The tumor suppressor RASSF1A and MAP-1 link death receptor signaling to Bax conformational change and cell death. Mol Cell 18: 637-650.
3. Beal MF, Brouillet E, Jenkins BG, Ferrante RJ, Kowall NW, Miller JM, Storey E, Srivastava R, Rosen BR, Hyman BT. 1993. Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J Neurosci 13: 4181-4192.
4. Chen HM, Wang L, D'Mello SR. 2008. Inhibition of ATF-3 expression by B-Raf mediates the neuroprotective action of GW5074. J Neurochem 105: 1300-1312.
5. Chin PC, Liu L, Morrison BE, Siddiq A, Ratan RR, Bottiglieri T, D'Mello SR. 2004. The c-Raf inhibitor GW5074 provides neuroprotection in vitro and in an animal model of neurodegeneration through a MEK-ERK and Akt-independent mechanism. J Neurochem 90: 595-608.
6. Dalmau J, Gultekin SH, Voltz R, Hoard R, DesChamps T, Balmaceda C, Batchelor T, Gerstner E, Eichen J, Frennier J, Posner JB, Rosenfeld MR. 1999. Ma1, a novel neuron- and testis-specific protein, is recognized by the serum of patients with paraneoplastic neurological disorders. Brain 122: 27-39.
7. 1H-NMR spectroscopy study of metabolic impairment in primates chronically treated with the succinate dehydrogenase inhibitor 3-nitropropionic acid. Neurobiol Dis 6: 259-268.
8. D'Mello SR, Galli C, Ciotti T, Calissano P. 1993. Induction of apoptosis in cerebellar granule neurons by low potassium: inhibition of death by insulin-like growth factor I and cAMP. Proc Natl Acad Sci U S A 90: 10989-10993.
9. Foley CJ, Freedman H, Choo SL, Onyskiw C, Fu NY, Yu VC, Tuszynski J, Pratt JC, Baksh S. 2008. Dynamics of RASSF1A/MOAP-1 association with death receptors. Mol Cell Biol 28: 4520-4535.
10. Fu NY, Sukumaran SK, Yu VC. 2007. Inhibition of ubiquitin-mediated degradation of MOAP-1 by apoptotic stimuli promotes Bax function in mitochondria. Proc Natl Acad Sci U S A 104: 10051-10056.
11. Koulich E, Nguyen T, Johnson K, Giardina C, D'Mello S. 2001. NF-kappaB is involved in the survival of cerebellar granule neurons: association of IkappaBbeta [correction of Ikappabeta] phosphorylation with cell survival. J Neurochem 76: 1188-1198.
12. Li JY, Popovic N, Brundin P. 2005. The use of the R6 transgenic mouse models of Huntington's disease in attempts to develop novel therapeutic strategies. NeuroRx 2: 447-464.
13. Majdzadeh N, Wang L, Morrison BE, Bassel-Duby R, Olson EN, D'Mello SR. 2008. HDAC4 inhibits cell-cycle progression and protects neurons from cell death. Dev Neurobiol 68: 1076-1092.
14. Murphy TH, Schnaar RL, Coyle JT. 1990. Immature cortical neurons are uniquely sensitive to glutamate toxicity by inhibition of cystine uptake. FASEB J 4: 1624-1633.
15. Ortiz-Vega S, Khokhlatchev A, Nedwidek M, Zhang XF, Dammann R, Pfeifer GP, Avruch J. 2002. The putative tumor suppressor RASSF1A homodimerizes and heterodimerizes with the Ras-GTP binding protein Nore1. Oncogene 21: 1381-1390.
16. Schuller M, Jenne D, Voltz R. 2005. The human PNMA family: novel neuronal proteins implicated in paraneoplastic neurological disease. J Neuroimmunol 169: 172-176.
17. Takaji M, Komatsu Y, Watakabe A, Hashikawa T, Yamamori T. 2009. Paraneoplastic antigen-like 5 gene (PNMA5) is preferentially expressed in the association areas in a primate specific manner. Cereb Cortex 19: 2865-2879.
18. Tan KO, Tan KM, Chan SL, Yee KS, Bevort M, Ang KC, Yu VC. 2001. MAP-1, a novel proapoptotic protein containing a BH3-like motif that associates with Bax through its Bcl-2 homology domains. J Biol Chem 276: 2802-2807.
19. Tan KO, Fu NY, Sukumaran SK, Chan SL, Kang JH, Poon KL, Chen BS, Yu VC. 2005. MAP-1 is a mitochondrial effector of Bax. Proc Natl Acad Sci U S A 102: 14623-14628.
20. Voltz R. 2002. Paraneoplastic neurological syndromes: an update on diagnosis, pathogenesis, and therapy. Lancet Neurol 1: 294-305.
21. Vos MD, Dallol A, Eckfeld K, Allen NP, Donninger H, Hesson LB, Calvisi D, Latif F, Clark GJ. 2006. The RASSF1A tumor suppressor activates Bax via MOAP-1. J Biol Chem 281: 4557-4563.
22. Yalcin A, Koulich E, Mohamed S, Liu L, D'Mello SR. 2003. Apoptosis in cerebellar granule neurons is associated with reduced interaction between CREB-binding protein and NF-kappaB. J Neurochem 84: 397-408.